PLAIO
PLAIO is an Icelandic AI-powered supply chain planning platform that unifies demand forecasting, supply planning, and production scheduling for mid-market and enterprise pharmaceutical manufacturers, embedding pharma-specific constraints like batch sizes, shelf life, and regulatory requirements into its planning engine.
- Company typePrivate
- Founded2021
- HeadquartersReykjavík, Iceland
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What PLAIO does
PLAIO is an Icelandic software company that has built an AI-powered supply chain planning platform purpose-built for pharmaceutical manufacturers. Founded in 2021 by Jóhann Guðbjargarson and headquartered in Reykjavik, the company unifies demand forecasting, supply planning, and production scheduling into a single connected environment, with pharmaceutical-specific constraints (batch sizes, shelf-life tracking, CMO management, regulatory requirements, cleaning cycles, quality release timing) embedded directly into its AI planning engine. The product consists of three core modules (Demand, Supply, Production) plus supporting add-ons including the AI Coplanner, Consensus Planning, Exception Management, Pharma Constraints, Data Management, and Onboarding, all sharing a common data layer and integrating with ERP, MES, and LIMS systems via APIs.
PLAIO monetizes through annual SaaS subscriptions on a quote-based pricing model targeting mid-market pharmaceutical manufacturers (transitioning from spreadsheets) and enterprise pharmaceutical companies (requiring planning capabilities beyond legacy ERP), with a secondary segment in Contract Development and Manufacturing Organizations (CDMOs). The go-to-market is enterprise field sales with a demo-driven evaluation cycle, supported by active presence at major industry events (BIO International Convention, CPHI Europe, LogiPharma) and a strategic channel partnership with Sikich for NetSuite-enabled life sciences deployments. The company operates from Reykjavik and Copenhagen, has raised approximately €6.3 million across two rounds (€2M pre-Series A in December 2021 from Frumtak Ventures, €4.3M in August 2024 led by Kvika Asset Management's Iðunn fund), and has a publicly disclosed customer base including Eisai, Azurity, MS Pharma, Coripharma, Navamedic, and AGM Pharma.
PLAIO firmographics
Firmographics- Name
- PLAIO
- Legal name
- PLAIO
- Website
- https://plaio.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PLAIO is an Icelandic AI-powered supply chain planning platform that unifies demand forecasting, supply planning, and production scheduling for mid-market and enterprise pharmaceutical manufacturers, embedding pharma-specific constraints like batch sizes, shelf life, and regulatory requirements into its planning engine.
- Ownership category
- akta.pro rank
PLAIO industry classification
Industry- Product category
- Pharmaceutical Supply Chain Planning Software
- NAICS
- Software Publishers (5132)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Supply Chain Planning (S&OP/IBP, Demand & Inventory) (BPAHAHAD)
- akta.pro secondary industry
- B2B/EDI & Supply Chain Process Automation Platforms (HDAEAHAK)
Keywords
Where PLAIO is headquartered
LocationHeadquarters
- HQ city
- Reykjavík
- HQ country
- Iceland
- HQ region
- Europe
Offices2 records
Markets served
PLAIO business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- SaaS Software Licenses (Subscription): PLAIO generates revenue through SaaS subscription licensing of its AI-powered pharmaceutical supply chain planning platform. Pricing is quote-based, reflecting enterprise and mid-market target segments with tiered plans.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise tier for large pharmaceutical manufacturers with multi-site, complex planning needs |
| Subscription | Annual | Mid-market tier for mid-sized pharmaceutical companies transitioning from spreadsheets |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
PLAIO product offering
Product offeringCore offering
PLAIO sells an AI-powered pharmaceutical supply chain planning SaaS platform that unifies demand forecasting, supply planning, and production scheduling in a single environment built specifically for pharmaceutical manufacturers. The platform embeds pharma-native constraints (batch sizes, shelf life, CMO management, regulatory requirements, cleaning cycles, quality release timing) directly into its AI planning engine and is augmented by the AI Coplanner for natural-language scenario planning. It is delivered as a subscription with quote-based, tiered pricing for enterprise and mid-market pharma customers and integrates with ERP, MES, and LIMS systems via APIs.
Product overview
PLAIO is an AI-powered pharmaceutical supply chain planning platform offered as a unified system with three core integrated modules (Demand, Supply, and Production) plus supporting add-on modules. The core platform unifies demand forecasting, supply planning, and production scheduling into a single connected environment. The Demand module uses AI-powered forecasting with machine learning, the Supply module handles inventory and procurement optimization with multi-echelon capabilities, and the Production module provides constraint-aware scheduling. Supporting modules include AI Coplanner (AI-assisted calculations), Consensus Planning, Exception Management, Pharma Constraints, Data Management, and Onboarding. All modules share a common data layer and integrate with ERP, MES, and LIMS systems.
Differentiator
Problem solved
Functional benefit
Products and services
- PLAIO Platform Unified AI-powered pharmaceutical supply chain planning SaaS platform that integrates AI-powered demand forecasting, automated supply planning across multi-echelon networks, and constraint-based production scheduling in a single environment built specifically for pharmaceutical manufacturers. Includes the Pharma Constraints Engine (CMO management, shelf-life tracking, regulatory requirements, batch sizes, cleaning cycles, quality release timing), consensus planning, exception management, and ERP/MES/LIMS integration via APIs. Sold on a subscription basis to enterprise and mid-market pharmaceutical manufacturers.
- AI Coplanner AI-assisted decision support feature within the PLAIO Platform that uses machine learning to optimize supply plan calculations, enable natural-language scenario planning, generate executive briefings grounded in live data, and conduct real-time supplier risk assessment. Augments human planners with automated calculations across capacity, lead times, and minimum order quantity constraints specific to pharmaceutical manufacturing.
Quantifiable outcome
- Forecast accuracy improvement up to 80%
- +4 more outcomes
Companies that use PLAIO
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
PLAIO technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability8 records
Feature8 records
PLAIO partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and flagship.
- SikichcoreStrategic partnership between PLAIO and Sikich to improve supply chain capabilities for pharmaceutical companies by integrating PLAIO's AI planning software with ERP systems and enhancing predictive analytics. The collaboration aims to unify planning processes, improve transparency, and support the industry's shift toward adaptive planning models. Sikich brings NetSuite capabilities tailored for Life Science operations and implementation expertise. Joint presence at BIO International Convention 2026 (booth #3350).
- EisaiflagshipPLAIO announced a partnership with Eisai to use PLAIO's advanced planning solution for global supply chain planning and distribution. The collaboration leverages PLAIO's AI-assisted planning platform to establish a sustainable, reliable global supply chain that meets increasing demands for Eisai's oncology and neurology treatments. The AI-powered Coplanner feature enables detailed planning and simulation for supply chain managers to effectively allocate resources for production scaling.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
PLAIO competitors and assessment
Company assessmentOthers
Direct peers
- Kinaxis: Kinaxis (formerly Logility) offers AI-driven supply chain planning including demand, supply, and production planning for life sciences manufacturers. Directly comparable to PLAIO across core functional modules and target pharma buyer, though Kinaxis serves a broader set of industries and is significantly larger.
- o9 Solutions: o9 Solutions provides an AI-powered integrated business planning platform covering demand forecasting, supply planning, and scenario planning. Comparable to PLAIO in its AI-first, unified planning architecture and its pursuit of large enterprise customers including those in life sciences.
- RELEX Solutions: RELEX Solutions delivers unified supply chain and retail planning software with strong forecasting and inventory optimization capabilities. Comparable to PLAIO in unifying demand-supply planning on a single platform and serving mid-market to enterprise customers, including in pharma-adjacent verticals.
- ToolsGroup: ToolsGroup provides AI-driven demand planning, inventory optimization, and supply chain analytics with deep pharma and CPG exposure. Directly competes with PLAIO on probabilistic forecasting, multi-echelon inventory optimization, and service-level-driven planning for life sciences manufacturers.
- Dassault Systèmes DELMIA Quintiq: Quintiq (now part of Dassault Systèmes DELMIA) provides advanced planning, scheduling, and optimization software with strong production scheduling capabilities. Directly comparable to PLAIO's production planning module and frequently used in life sciences and process manufacturing for complex constraint-based scheduling.
- E2open: E2open provides a connected supply chain platform spanning demand, supply, production, and logistics planning with significant life sciences vertical exposure. Comparable to PLAIO across integrated planning workflows and enterprise customer profile, though E2open operates at significantly larger scale and breadth.
Broad incumbents
- Blue Yonder: Blue Yonder (formerly JDA Software) is a large, established supply chain planning and execution platform serving multiple industries including pharma. Comparable to PLAIO across demand, supply, and production planning capabilities, but as a much broader incumbent with extensive enterprise ERP-adjacent functionality.
- Oracle Supply Chain Planning: Oracle SCM Planning, including Oracle Demantra and Oracle Supply Planning, is widely deployed in large pharma manufacturers. Comparable to PLAIO on core planning capabilities but as a broad incumbent whose planning modules are typically purchased alongside Oracle ERP, raising the switching cost barrier for PLAIO.
Emerging players
- AIMMS (SymphonyAI): AIMMS, now part of SymphonyAI, provides a supply chain analytics and optimization platform with prescriptive planning capabilities. Comparable to PLAIO's AI Coplanner and constraint-based optimization positioning, often used by mid-market manufacturers seeking flexible planning customization.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
PLAIO social profiles
Digital presencePLAIO financial estimates
Financial estimateRevenue estimate
Valuation estimate
PLAIO leadership team
Management profileNumber of profiles
Profiles6 records
PLAIO funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PLAIO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PLAIO
What does PLAIO do?
PLAIO sells an AI-powered pharmaceutical supply chain planning SaaS platform that unifies demand forecasting, supply planning, and production scheduling in a single environment built specifically for pharmaceutical manufacturers. The platform embeds pharma-native constraints (batch sizes, shelf life, CMO management, regulatory requirements, cleaning cycles, quality release timing) directly into its AI planning engine and is augmented by the AI Coplanner for natural-language scenario planning. It is delivered as a subscription with quote-based, tiered pricing for enterprise and mid-market pharma customers and integrates with ERP, MES, and LIMS systems via APIs.
Is PLAIO a public or private company?
PLAIO is a private company. It is classified as venture growth investor backed and is currently operating.
When was PLAIO founded?
PLAIO was founded in 2021. It employs 11 to 50 people.
Where is PLAIO based?
PLAIO is headquartered in Reykjavík, Iceland, in the Europe region.
How does PLAIO make money?
One revenue line is on record: saaS Software Licenses (Subscription).
Who are PLAIO's main competitors?
SAP Integrated Business Planning is listed as an others. Direct peers are Kinaxis, o9 Solutions, RELEX Solutions, ToolsGroup, Dassault Systèmes DELMIA Quintiq and E2open. Broad incumbents are Blue Yonder and Oracle Supply Chain Planning. AIMMS (SymphonyAI) is listed as an emerging player.
Does PLAIO have an API?
No public API is recorded for PLAIO.
What industry is PLAIO in?
PLAIO's product category is Pharmaceutical Supply Chain Planning Software. Its primary akta.pro industry code is BPAHAHAD, Supply Chain Planning (S&OP/IBP, Demand & Inventory), with a secondary code of HDAEAHAK, B2B/EDI & Supply Chain Process Automation Platforms. Its NAICS code is 5132 and its SIC code is 7372.